Entasis Therapeutics Holdings Inc.

Entasis Therapeutics Holdings Inc.verified

ETTX

Price:

$2.19

Market Cap:

$0

Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibacterial products to treat serious infections caused by multidrug-resistant pathogens in the United States. Its lead product candidate is sulbactam-durlobactam (SUL-DUR), a novel IV antibiotic that is in Phase III clinical trial for the treatment of pneumonia and bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii. The company also develops Zoliflodacin, a novel orally administered molecule, which is in Phase III clinical trial for the treatment of uncomplicated gonorrhea; ETX0282CPDP, an oral drug that is in Phase I cl...[Read more]

Industry

Biotechnology

IPO Date

2018-09-26

Stock Exchange

NASDAQ

Ticker

ETTX

The ROE as of November 2025 (TTM) for Entasis Therapeutics Holdings Inc. (ETTX) is -112.91%

According to Entasis Therapeutics Holdings Inc.’s latest financial reports and current stock price. The company's current ROE is -112.91%. This represents a change of 52.84% compared to the average of -73.87% of the last 4 quarters.

Entasis Therapeutics Holdings Inc. (ETTX) Historical ROE (quarterly & annually)

How has ETTX ROE performed in the past?

The mean historical ROE of Entasis Therapeutics Holdings Inc. over the last ten years is -44.21%. The current -112.91% ROE has changed 155.40% with respect to the historical average. Over the past ten years (40 quarters), ETTX's ROE was at its highest in in the December 2017 quarter at 16.44%. The ROE was at its lowest in in the December 2021 quarter at -151.03%.

Quarterly (TTM)
Annual

Average

-44.21%

Median

-68.16%

Minimum

-151.03%

Maximum

72.49%

Entasis Therapeutics Holdings Inc. (ETTX) ROE by Quarter and Year

Discovering the peaks and valleys of Entasis Therapeutics Holdings Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 161.63%

Maximum Annual ROE = 72.49%

Minimum Annual Increase = -174.13%

Minimum Annual ROE = -151.03%

Quarterly (TTM)
Annual
YearROEChange
2021-151.03%56.40%
2020-96.57%-7.16%
2019-104.02%161.63%
2018-39.76%-174.13%
201753.64%-26.01%

Entasis Therapeutics Holdings Inc. (ETTX) Average ROE

How has ETTX ROE performed in the past?

The current ROE of Entasis Therapeutics Holdings Inc. (ETTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-117.21%

5-year avg

-67.55%

10-year avg

-44.21%

Entasis Therapeutics Holdings Inc. (ETTX) ROE vs. Peers

How is ETTX’s ROE compared to its peers?

Entasis Therapeutics Holdings Inc.’s ROE is greater than HilleVax, Inc. (-44.61%), greater than Jounce Therapeutics, Inc. (-25.03%), greater than Cyteir Therapeutics, Inc. (-26.35%), greater than RVL Pharmaceuticals plc (-80.88%), less than Opiant Pharmaceuticals, Inc. (7.31%), greater than Tourmaline Bio, Inc. (-30.50%), less than Paratek Pharmaceuticals, Inc. (42.54%), greater than Aadi Bioscience, Inc. (-8.09%), greater than Decibel Therapeutics, Inc. (-56.38%), greater than Miromatrix Medical Inc. (-74.80%),

Build a custom stock screener for Entasis Therapeutics Holdings Inc. (ETTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Entasis Therapeutics Holdings Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Entasis Therapeutics Holdings Inc. (ETTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Entasis Therapeutics Holdings Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Entasis Therapeutics Holdings Inc.'s ROE?

How is the ROE calculated for Entasis Therapeutics Holdings Inc. (ETTX)?

What is the highest ROE for Entasis Therapeutics Holdings Inc. (ETTX)?

What is the 3-year average ROE for Entasis Therapeutics Holdings Inc. (ETTX)?

What is the 5-year average ROE for Entasis Therapeutics Holdings Inc. (ETTX)?

How does the current ROE for Entasis Therapeutics Holdings Inc. (ETTX) compare to its historical average?